September 16 - 18, 2020


Registration Deadline: November 30, 2020
Virtual Platform Close Date: December 15, 2020


Registration Deadline: November 30, 2020
Virtual Platform Close Date: December 15, 2020

Live Session 1: September 16, 2020 1:30 PM - 6:45 PM
Live Session 2: September 17, 2020 1:30 PM - 6:15 PM
Live Session 3: September 18, 2020 9:30 AM - 2:00 PM


On-Demand Sessions Will Include:

The Role of the FDA in Device Evaluation and Approval: An Overview
Martin I. Golding, MD

Cardiac Manifestations of Patients with Liver Disease
Marc Klapholz, MD, MBA

Maximizing the Donor Potential for Liver Transplant
James V. Guarrera, MD


Topics at this learning-focused CME/CE conference include:
  • NASH
  • Hepatitis B & C
  • Irritable Bowel Syndrom
  • Gastroesophageal Reflux Disease
  • Inflammatory Bowel Disease
  • Colorectal Cancer Screening
  • Primary Biliary Cholangitis
  • Gut Microbiota and Liver Disease
  • Liver Cancer
  • and much more!

Dear Colleagues:

We are pleased to present the 7th Annual Digestive Diseases: New Advances CME/CE conference as a virtual event.

Complexity and magnitude of medical advances in the management of digestive diseases make it ever more challenging for clinicians to apply this tremendous amount of information to their practice.

This online learning experience will provide learners with a comprehensive overview of the state-of-the art advances in the diagnostic, therapeutic and preventive modalities of digestive diseases based on the latest evidence, literature and clinical research. A thorough review of the current treatment landscape is vital to both clinicians and patients who can benefit from the expansion of therapeutic options.

Interactive sessions offer attendees the chance to ask difficult questions and discuss patient care options with the experts. The format is interactive, informal and relaxed, encouraging a free-flowing exchange of ideas and practical solutions for the busy clinician.

We hope you can join us in this virtual conference experience!


Nikolaos T. Pyrsopoulos, MD



Nikolaos T. Pyrsopoulos, MD, PhD, MBA, FACP, AGAF, FAASLD, FRCP (Edin)
Professor of Medicine and Chief, Division of Gastroenterology and Hepatology
Professor of Physiology, Pharmacology and Neuroscience
Rutgers New Jersey Medical School
Medical Director Liver Transplantation
University Hospital
Newark, NJ

Follow Us

Jointly Provided By